These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14203198)

  • 1. ENDOGENEOUS PERMEABILITY FACTORS AND THEIR INHIBITORS AFFECTING VASCULAR PERMEABILITY IN CUTANEOUS ARTHUS REACTIONS AND THERMAL INJURY.
    HAYASHI H; YOSHINAGA M; KOONO M; MIYOSHI H; MATSUMURA M
    Br J Exp Pathol; 1964 Aug; 45(4):419-35. PubMed ID: 14203198
    [No Abstract]   [Full Text] [Related]  

  • 2. ENDOGENEOUS MECHANISMS IN INCREASED VASCULAR PERMEABILITY IN INFLAMMATION.
    HAYASHI H
    Acta Pathol Jpn; 1963 Oct; 13():213-5. PubMed ID: 14195178
    [No Abstract]   [Full Text] [Related]  

  • 3. THE RELEASE OF VASCULAR PERMEABILITY FACTORS BY HOMOLOGOUS ANTIGEN AND BY SOLUBLE ANTIGEN-ANTIBODY COMPLEXES IN TISSUE CULTURE AND ITS BIOLOGIC SIGNIFICANCE.
    HAYASHI H; KINUWAKI Y; KOONO M; TAKABA Y
    Lab Invest; 1964 Sep; 13():1124-38. PubMed ID: 14207887
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of kinin, kallidin, and bradykinin.
    HOLDSTOCK DJ; MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):149-58. PubMed ID: 13446366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRADYKININOGEN, ANGIOTENSINOGEN AND KALLIDINOGEN.
    FASCIOLO JC
    Br J Pharmacol Chemother; 1963 Oct; 21(2):250-8. PubMed ID: 14081656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FURTHER STUDIES OF THE SENSITIZATION OF SMOOTH MUSCLE TO THE ACTION OF PLASMA KININS BY PROTEOLYTIC ENZYMES.
    EDERY H
    Br J Pharmacol Chemother; 1965 Apr; 24(2):485-96. PubMed ID: 14320863
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EVALUATION OF INCREASED VASCULAR PERMEABILITY IN THE SKIN OF GUINEA-PIGS.
    CARR J; WILHELM DL
    Aust J Exp Biol Med Sci; 1964 Aug; 42():511-22. PubMed ID: 14202191
    [No Abstract]   [Full Text] [Related]  

  • 8. THE ANTAGONISM OF SUBSTANCES THAT INCREASE VASCULAR PERMEABILITY IN THE RAT.
    SPECTOR WG; WILLOUGHBY DA
    J Pathol Bacteriol; 1963 Oct; 86():487-96. PubMed ID: 14068957
    [No Abstract]   [Full Text] [Related]  

  • 9. A PERMEABILITY FACTOR RELEASED FROM LEUKOCYTES AFTER PHAGOCYTOSIS OF IMMUNE COMPLEXES AND ITS POSSIBLE ROLE IN THE ARTHUS REACTION.
    MOVAT HZ; URIUHARA T; MACMORINE DL; BURKE JS
    Life Sci (1962); 1964 Sep; 3():1025-32. PubMed ID: 14206043
    [No Abstract]   [Full Text] [Related]  

  • 10. An endogeneous mechanism of increased vascular permeability in allergic inflammation: anti-permeability factor newly isolated from Arthus lesion and its biologic significance.
    Koono M
    Kumamoto Med J; 1966 Jun; 19(2):79-89. PubMed ID: 4226039
    [No Abstract]   [Full Text] [Related]  

  • 11. FURTHER STUDY OF CORRELATIVE BEHAVIOR BETWEEN SPECIFIC PROTEASE AND ITS INHIBITOR IN CUTANEOUS ARTHUS REACTIONS.
    HAYASHI H; UDAKA K; MIYOSHI H; KUDO S
    Lab Invest; 1965 Jun; 14():665-73. PubMed ID: 14319955
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on smooth muscle and blood vessels of polypeptides related to bradykinin and to kallidin.
    RUBIN B; WAUGH MH; LAFFAN RJ; O'KEEFE E; CRAVER EN
    Proc Soc Exp Biol Med; 1963 Jun; 113():328-32. PubMed ID: 13982987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological differences between bradykinin and kallidin].
    HOLTZ P; BARCK S; HEICKE B
    Arch Int Pharmacodyn Ther; 1962 Nov; 140():79-83. PubMed ID: 13961475
    [No Abstract]   [Full Text] [Related]  

  • 14. Analgesic-antipyretic drugs as inhibitors of kallikrein.
    NORTHOVER BJ; SUBRAMANIAN G
    Br J Pharmacol Chemother; 1961 Aug; 17(1):107-15. PubMed ID: 13729628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory changes in small blood vessels induced by kallikrein (kininogenase) in the blood of Macaca mulatta infected with Plasmodium knowlesi.
    Onabanjo AO; Maegraith BG
    Ann Trop Med Parasitol; 1970 Jun; 64(2):227-36. PubMed ID: 4992593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bradykinin, kallidin and hypertension].
    WERLE E; KEHL R; KOEBKE K
    Biochem Z; 1950; 320(4):372-83. PubMed ID: 14777780
    [No Abstract]   [Full Text] [Related]  

  • 17. THE LYMPH NODE PERMEABILITY FACTOR: A POSSIBLE MEDIATOR OF THE DELAYED HYPERSENSITIVITY REACTION.
    WILLOUGHBY DA; SPECTOR WG
    Ann N Y Acad Sci; 1964 Aug; 116():874-9. PubMed ID: 14212860
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE EFFECT OF BRADYKININ, KALLIDIN AND ELEDOISIN ON THE CAT AND RABBIT INTESTINE IN SITU].
    WINKLER H; BAUER G; GMEINER R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Apr; 250():459-68. PubMed ID: 14336580
    [No Abstract]   [Full Text] [Related]  

  • 19. [STRUCTURE AND FUNCTION OF THE BIOLOGICALLY ACTIVE PEPTIDES: BRADYKININ, KALLIDIN, ANGIOTENSIN AND SUBSTANCE P].
    MICHAUD J
    Presse Med (1893); 1964 Oct; 72():2693-8. PubMed ID: 14226744
    [No Abstract]   [Full Text] [Related]  

  • 20. Actions of some peptides on bronchial muscle.
    BHOOLA KD; COLLIER HO; SCHACHTER M; SHORLEY PG
    Br J Pharmacol Chemother; 1962 Aug; 19(1):190-7. PubMed ID: 13868845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.